BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36585729)

  • 1. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
    Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
    Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
    Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
    Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
    Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
    Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
    Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
    Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
    Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication.
    Lambros MB; Tan DS; Jones RL; Vatcheva R; Savage K; Tamber N; Fenwick K; Mackay A; Ashworth A; Reis-Filho JS
    J Clin Pathol; 2009 Jul; 62(7):604-12. PubMed ID: 19561229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
    Laé M; Fréneaux P; Sastre-Garau X; Chouchane O; Sigal-Zafrani B; Vincent-Salomon A
    Mod Pathol; 2009 Feb; 22(2):291-8. PubMed ID: 19011601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
    Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
    Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory Carcinoma with ETV6-NTRK3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
    Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
    Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.
    Chen M; Pu T; Wei B; Bu H; Tang P; Zhang Z
    Pathol Res Pract; 2022 Mar; 231():153790. PubMed ID: 35158121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry.
    Diallo R; Schaefer KL; Bankfalvi A; Decker T; Ruhnke M; Wülfing P; Jackisch C; Luttges J; Sorensen PH; Singh M; Poremba C
    Hum Pathol; 2003 Dec; 34(12):1299-305. PubMed ID: 14691916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
    Su YJ; Lee YH; Jin YT; Hsieh MS
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
    Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
    Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast.
    Harrison BT; Fowler E; Krings G; Chen YY; Bean GR; Vincent-Salomon A; Fuhrmann L; Barnick SE; Chen B; Hosfield EM; Hornick JL; Schnitt SJ
    Am J Surg Pathol; 2019 Dec; 43(12):1693-1700. PubMed ID: 31498178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
    Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
    Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.
    Suzuki K; Harada H; Takeda M; Ohe C; Uemura Y; Kawahara A; Sawada S; Kanda A; Sengupta B; Iwai H
    BMC Med Genomics; 2022 Jan; 15(1):6. PubMed ID: 34991563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic features of secretory breast carcinoma].
    Zhang F; Shi M; Liao Q; Zhou CM
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):628-632. PubMed ID: 31434456
    [No Abstract]   [Full Text] [Related]  

  • 18. Secretory carcinoma of the sinonasal cavity and pharynx: A retrospective analysis of four cases and literature review.
    Yue C; Zhao X; Ma D; Piao Y
    Ann Diagn Pathol; 2022 Dec; 61():152052. PubMed ID: 36270241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical/unbalanced ETV6/NTRK3 rearrangement in salivary secretory carcinoma with a focus on the incidence, the patterns, and the clinical implications.
    Sun J; Li J; Tian Z; Zhang C; Xia R; He Y
    J Oral Pathol Med; 2022 Sep; 51(8):721-729. PubMed ID: 36087274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
    Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
    Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.